Search research articles
Contact Us
Filters
Showing results (251-260 of 297) with videos related to
Page
of 30
Sort By:
Plos One
|
March 17, 2018
Clinical management and outcomes of patients with Hermansky-Pudlak syndrome pulmonary fibrosis evaluated for lung transplantation
Souheil El-Chemaly, Kevin J O'Brien, Steven D Nathan, et al.
ERJ Open Research
|
January 30, 2024
An adjudication algorithm for respiratory-related hospitalisation in idiopathic pulmonary fibrosis
Paul Ford, Michael Kreuter, Kevin K Brown, et al.
The European Respiratory Journal
|
July 31, 2025
Early Post-Transplant Recipient Tissue Injury Predicts Allograft Function, Rejection, and Survival in Lung Transplant Recipients, Evidence from Cell-free DNA
Muhtadi Alnababteh, Michael B Keller, Hyesik Kong, et al.
ERJ Open Research
|
December 24, 2025
Survival in patients with pulmonary hypertension associated with fibrotic interstitial lung disease (ILD) is independent of ILD subtype
Ifan Jenkin, Konstantinos Dimopoulos, Steven D Nathan, et al.
Chest
|
February 17, 2022
Screening Strategies for Pulmonary Hypertension in Patients With Interstitial Lung Disease: A Multidisciplinary Delphi Study
Franck F Rahaghi, Nicholas A Kolaitis, Ayodeji Adegunsoye, et al.
Chest
|
May 11, 2020
A Molecular Classifier That Identifies Usual Interstitial Pneumonia in Transbronchial Biopsy Specimens of Patients With Interstitial Lung Disease
Ganesh Raghu, Thomas V Colby, Jeffrey L Myers, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
June 16, 2021
Donor-derived cell-free DNA accurately detects acute rejection in lung transplant patients, a multicenter cohort study
Moon Kyoo Jang, Ilker Tunc, Gerald J Berry, et al.
The New England Journal of Medicine
|
March 11, 2026
Inhaled Treprostinil for Idiopathic Pulmonary Fibrosis
Steven D Nathan, Peter Smith, Chunqin Deng, et al.
The New England Journal of Medicine
|
May 20, 2014
A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis
Talmadge E King, Williamson Z Bradford, Socorro Castro-Bernardini, et al.
The European Respiratory Journal
|
May 29, 2024
Inhaled treprostinil in pulmonary hypertension associated with COPD: PERFECT study results
Steven D Nathan, Rahul Argula, Maria G Trivieri, et al.
Page
of 30
Search research articles
Search
Showing results (251-260 of 297) with videos related to
Sort By:
Page
of 30
Plos One
|
March 17, 2018
Clinical management and outcomes of patients with Hermansky-Pudlak syndrome pulmonary fibrosis evaluated for lung transplantation
Souheil El-Chemaly, Kevin J O'Brien, Steven D Nathan, et al.
ERJ Open Research
|
January 30, 2024
An adjudication algorithm for respiratory-related hospitalisation in idiopathic pulmonary fibrosis
Paul Ford, Michael Kreuter, Kevin K Brown, et al.
The European Respiratory Journal
|
July 31, 2025
Early Post-Transplant Recipient Tissue Injury Predicts Allograft Function, Rejection, and Survival in Lung Transplant Recipients, Evidence from Cell-free DNA
Muhtadi Alnababteh, Michael B Keller, Hyesik Kong, et al.
ERJ Open Research
|
December 24, 2025
Survival in patients with pulmonary hypertension associated with fibrotic interstitial lung disease (ILD) is independent of ILD subtype
Ifan Jenkin, Konstantinos Dimopoulos, Steven D Nathan, et al.
Chest
|
February 17, 2022
Screening Strategies for Pulmonary Hypertension in Patients With Interstitial Lung Disease: A Multidisciplinary Delphi Study
Franck F Rahaghi, Nicholas A Kolaitis, Ayodeji Adegunsoye, et al.
Chest
|
May 11, 2020
A Molecular Classifier That Identifies Usual Interstitial Pneumonia in Transbronchial Biopsy Specimens of Patients With Interstitial Lung Disease
Ganesh Raghu, Thomas V Colby, Jeffrey L Myers, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
June 16, 2021
Donor-derived cell-free DNA accurately detects acute rejection in lung transplant patients, a multicenter cohort study
Moon Kyoo Jang, Ilker Tunc, Gerald J Berry, et al.
The New England Journal of Medicine
|
March 11, 2026
Inhaled Treprostinil for Idiopathic Pulmonary Fibrosis
Steven D Nathan, Peter Smith, Chunqin Deng, et al.
The New England Journal of Medicine
|
May 20, 2014
A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis
Talmadge E King, Williamson Z Bradford, Socorro Castro-Bernardini, et al.
The European Respiratory Journal
|
May 29, 2024
Inhaled treprostinil in pulmonary hypertension associated with COPD: PERFECT study results
Steven D Nathan, Rahul Argula, Maria G Trivieri, et al.
Page
of 30